Alphamol Science Ltd. (shanghai)

This is the first study in humans for a new oral medication called Alpha-0261. It will test the safety and how the body processes the drug in 60 healthy adult volunteers. The main goal is to see what side effects occur and how the drug moves through the body at different doses.